MedVellum
MedVellum
Back to Library
Endocrinology
Rheumatology
Orthopaedics

Paget's Disease of Bone

High EvidenceUpdated: 2025-12-23

On This Page

Red Flags

  • New onset severe focal pain (Suspect Osteosarcoma)
  • High Output Cardiac Failure (rare)
  • Sudden hearing loss
Overview

Paget's Disease of Bone

[!WARNING] Medical Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. Medical guidelines and best practices change rapidly; users should verify information with current local protocols.

1. Overview

Paget's Disease of Bone (Osteitis Deformans) is a chronic disorder of bone remodelling. It involves excessive Resorption (by Osteoclasts) followed by chaotic Formation (by Osteoblasts), leading to disorganized, weak "woven" bone that is prone to deformity and fracture.

Clinical Scenario: The Tight Hat

A 70-year-old man presents with a dull ache in his right hip and deafness in his left ear. He mentions his hat size has increased over the last 5 years. Blood tests show an isolated Alkaline Phosphatase (ALP) of 900 IU/L (Normal <130).

Key Teaching Points

  • **Diagnosis**: **Paget's Disease**.
  • **Skull Enlargement**: Causes the hat sign and nerve compression (Deafness).
  • **Biochem**: **Isolated Raised ALP** is the hallmark. Calcium and Phosphate are usually normal (unlike Osteomalacia).
  • **Action**: Isotope Bone Scan to define extent.

2. Visual Summary Panel

Image Integration Plan

Image TypeSourceStatus
Management AlgorithmAI-generatedPENDING
Skull X-Ray (Cotton Wool)Web SourcePENDING
Tibial X-Ray (Sabre Shin)Web SourcePENDING
Histology (Mosaic Pattern)Web SourcePENDING

[!NOTE] Image Generation Status: Diagrams illustrating the Osteoclast-Osteoblast uncoupling are queued.

Phases of Disease

  1. Lytic Phase: Osteoclasts go wild. Resorption.
  2. Mixed Phase: Osteoblasts try to compensate. Chaotic bone formation.
  3. Sclerotic Phase: Osteoblasts dominate. Bone is hard, dense, but weak. (Burned out).

3. Epidemiology
  • Prevalence: Common in UK/Europe (up to 5% of men >55 years). Rare in Asia/Africa.
  • Age: >55 years.
  • Sex: Male > Female (3:2).
  • Genetics: SQSTM1 mutation in familial cases.

4. Pathophysiology
  1. Osteoclast Defect: Giant multi-nucleated osteoclasts resorb bone rapidly.
  2. Chaotic Repair: Osteoblasts lay down non-lamellar "woven" bone.
  3. Vascularity: The marrow becomes highly vascular (can feel warm on palpation).
  4. Result: Bones are expanded but structurally weak.

5. Clinical Presentation

Majority (70%) are Asymptomatic (Incidental high ALP).


Bone Pain
Deep, boring ache. Unrelenting. Worse on weight bearing (micro-fractures) but also present at rest (vascular distension).
Deformity
Skull: Frontal bossing. Tibia: Anterior bowing (Sabre Tibia). Femur: Lateral bowing.
Neurological
Deafness: Sensorineural (Cochlear damage) or Conductive (Ossicle sclerosis). Spinal Stenosis.
Cardiovascular
High Output Heart Failure (due to A-V shunting in vascular bone) - rare.
6. Clinical Examination
  1. Look: Deformity (Bowing)? Skull size?
  2. Feel: Increased warmth over the affected bone (vascularity).
  3. Move: Restricted ROM (secondary osteoarthritis).

7. Investigations
  • Biochemistry:
    • ALP: Markedly Elevated. Reflects extent of disease.
    • Calcium/Phosphate: Normal (Essential for exclusion of other metabolic bone disease).
    • Urine Hydroxyproline: High (marker of collagen breakdown).
  • X-Ray:
    • Skull: "Osteoporosis Circumscripta" (Lytic) -> "Cotton Wool Spots" (Sclerotic).
    • Long Bones: Thickened cortex, coarse trabeculation, bowing.
    • Vertebrae: "Picture Frame" Vertebrae.
  • Isotope Bone Scan: Most sensitive. Shows "Hot Spots" of activity.

8. Management

A. Indications for Treatment

Not everyone needs treatment. Treat if:

  1. Bone Pain.
  2. Neurological Complications (Deafness/Radiculopathy).
  3. Deformity.
  4. High Output Failure.
  5. Preparation for Surgery (e.g. Hip Replacement) - to reduce bleeding.

B. Pharmacotherapy

Goal: Suppress Osteoclasts.

  1. Bisphosphonates (Mainstay):
    • Zoledronic Acid: 5mg IV infusion (Single dose). Highly effective. Remission can last years. First line.
    • Risedronate: Oral (30mg daily for 2 months).
  2. Calcitonin: Rarely used now (less effective).

C. Analgesia

  • NSAIDs / Paracetamol.

D. Surgical

  • Joint Replacement (for secondary OA).
  • Osteotomy (for severe deformity).

9. Complications
  • Osteosarcoma (<1%):
    • Suspect if sudden increase in pain or new swelling.
    • Very poor prognosis.
  • Fractures: Chalk-stick fractures.
  • Hypercalcaemia: Only occurs if patient is immobilized.

10. Prognosis & Outcomes
  • Chronic progressive disease.
  • Treatment controls symptoms but does not reverse deformity.
  • Normal life expectancy (unless Osteosarcoma develops).

11. Evidence & Guidelines
  • Paget's Association Guidelines (UK).
  • PRISM Trial: Intensive vs Symptomatic management (showed intensive Rx didn't reduce fracture risk, but improved pain).

12. Patient & Layperson Explanation

What is Paget's Disease? Your bones are constantly being recycled – old bone is taken away and new bone is laid down. In Paget's, this process goes into overdrive. The "demolition crew" (osteoclasts) works too fast, and the "builders" (osteoblasts) panic and slap down new bone in a messy, chaotic way. The result is bone that is bigger and thicker than normal, but actually weaker and jumbled up.

Is it cancer? No. It is a benign metabolic condition. However, in very rare cases (less than 1 in 100), the active bone cells can turn into a bone cancer called osteosarcoma.

Why is my head getting bigger? The skull is a common place for this "overgrowth" to happen. As the bone thickens, it can make your hat feel tight and can sometimes squeeze the nerve to your ear, causing deafness.

How do we treat it? We use a drip called Zoledronic Acid. It acts like a brake on the "demolition crew", slowing the bone turnover back to normal speeds. One dose can work for years.


13. References
  1. Ralston SH, et al. Diagnosis and management of Paget's disease of bone in adults: A clinical guideline. J Bone Miner Res. 2019.
  2. Tan A, et al. Long-term randomized trial of intensive versus symptomatic management in Paget's disease of bone: The PRISM-EZ study. J Bone Miner Res. 2017.
  3. Reid IR, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med. 2005.

Last updated: 2025-12-23

At a Glance

EvidenceHigh
Last Updated2025-12-23

Red Flags

  • New onset severe focal pain (Suspect Osteosarcoma)
  • High Output Cardiac Failure (rare)
  • Sudden hearing loss

Clinical Pearls

  • **Image Generation Status**: Diagrams illustrating the Osteoclast-Osteoblast uncoupling are queued.
  • "Cotton Wool Spots" (Sclerotic).

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines